In the SURMOUNT-1 trial, patients lost an average of 15-21% of their initial body weight over 72 weeks, with results varying by dose and individual factors
By working on both GLP-1 and GIP receptors, tirzepatide increases insulin production in the pancreas, slows down digestion, and makes the body more sensitive to insulin
What does the clinical research say about modifying GLP-1 dosing schedules
JJH is a minority shareholder and board member of Antag Therapeutics and Bainan Biotech and has been a consultant for, has served on scientific advisory panels of, and has been speaker honoraria for Novo Nordisk and MSD/Merck
Otro elemento diferenciador de Mounjaro es la posibilidad de personalizar el tratamiento
If you have been struggling to get to a healthy weight and feeling confident about your body, semaglutide can help you make smarter food choices